CAS: 30516 -87-1 Zidovudine Powder

China CAS: 30516-87-1 Zidovudine Powder, Find details about China Zidovudine, 30516-87-1 from CAS: 30516-87-1 Zidovudine Powder

Model NO.
HNB-Zidovudine
Product Name
Zidovudine
CAS
30516-87-1
Molecular Weight
267.241
Molecular Formula
C10h13n5o4
Density
/
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
HPLC 99%
Origin
China
HS Code
3006920000
Model NO.
HNB-Zidovudine
Product Name
Zidovudine
CAS
30516-87-1
Molecular Weight
267.241
Molecular Formula
C10h13n5o4
Density
/
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
HPLC 99%
Origin
China
HS Code
3006920000
CAS: 30516-87-1 Zidovudine Powder
Cas:30516-87-1 Zidovudine powder
 
product nameZidovudine
cas number30516-87-1
apperanceWhite powder
Density/
MFC10H13N5O4
MW267.241

Zidovudine is an antiviral drug with a chemical formula of C10H13N5O4, used for the treatment of AIDS or AIDS-related syndromes and immunodeficiency virus (HIV) infection. On March 19, 1987, the US Food and Drug Administration approved the drug for marketing. Zidovudine is the world's first anti-AIDS drug approved by the US FDA. Because of its definite curative effect, it has become the most basic component of "cocktail" therapy. It is highly active against retroviruses including human immunodeficiency virus (HIV) in vitro. In virus-infected cells, it is phosphorylated by cellular thymidine kinase to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to the termination of HIV chain synthesis and preventing HIV replication.
CAS: 30516-87-1 Zidovudine PowderPharmacological action
This product is an antiviral drug, which is highly active against retroviruses including human immunodeficiency virus (HIV) in vitro. In virus-infected cells, it is phosphorylated by cellular thymidine kinase to zidovudine triphosphate, which can selectively inhibit HIV reversal enzyme, leading to the termination of HIV chain synthesis and preventing HIV replication.

CAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine Powder
CAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine Powder